How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

503 results for

Superficial Thrombophlebitis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Early experience of transilluminated cryosurgery for varicose vein with saphenofemoral reflux: review of 84 patients (131 limbs) (PubMed)

for varicose veins.One hundred thirty-one limbs in 84 patients (37 male, 47 female; mean age, 53.3 years) with varicose veins were treated with cryosurgery over a 2-year period. The patients were followed for postoperative complication with surveillance of recurrence. The analyzed variables included age, sex, symptom, operative time (from skin incision to the application of elastic bandages on the legs for compression purposes), and postoperative complications including bruising, hematoma, superficial (...) thrombophlebitis, cellulitis, seroma, cutaneous nerve damage, and wound complication.The mean operative time was 64.7 minutes for both limbs and 44 minutes for single limbs. The median number of incisions was 2. For stripping of GSV, one incision at the groin was necessary. Postoperative complications included an episode of hematoma in 3 limbs (2.3%), cutaneous nerve damage in 3 limbs (2.3%), cellulitis in 2 patients (1.5%), and seroma in 1 limb (0.8%). No wound infection, thrombophlebitis or deep venous

Full Text available with Trip Pro

2017 Annals of surgical treatment and research

142. Penile Mondor's disease in a patient treated with radical chemoradiation for anal cancer (PubMed)

Penile Mondor's disease in a patient treated with radical chemoradiation for anal cancer Penile Mondor's disease is a rare condition characterized by sclerosing thrombophlebitis of the superficial dorsal penile vein. Usually its causes are benign, but it is also evident in cancer patients. We report the case of a 62-year-old man with a cT4 anal cancer (infiltration of corpora spongiosa and penile bulb), associated with extensive loco-regional lymphadenopathy, who developed painful lumps

Full Text available with Trip Pro

2017 Oxford Medical Case Reports

144. Varicose veins. Natural history, assessment and management.

be a good reason to refer them for a specialist opinion. there is extensive debate on the treatment of patients with uncomplicated varicose veins in the public health system, with much to be said for a very conservative approach in this category of patients. some funding agencies will not support payment for this group. many public guidelines, including Australian guidelines, suggest that only • skin pigmentation • eczema. less common symptoms include ulceration, superficial thrombophlebitis (...) , disadvantages and long term outcomes. Objective To describe the natural history, assessment and management of varicose veins. Discussion Surgical or other intervention is only necessary in a small percentage of patients, and is seldom urgent, perhaps only in the setting of progressive thrombophlebitis. Duplex ultrasound has become an essential modality for diagnosis, treatment and follow up. All the current modalities of endoluminal and open surgical treatment have similar short term outcomes and risks

2013 Clinical Practice Guidelines Portal

145. Contraception in women at cardiovascular risk

, with or without aura. ´ Tobacco consumption. Generalities How to identify a woman at cardiovascular risk? ´ Deep vein thrombosis (DVT)/pulmonary embolism (PE). ´ Superficial thrombophlebitis. ´ Hereditary thrombosis risk factors (factor V Leiden mutation [Factor V Leiden], 20210G>A mutation of the prothrombin gene [FII 20210A], antithrombin [AT], protein C [PC], protein S [PS] deficiency). ´ Stroke. ´ Ischaemic heart disease. ´ Cardiac valvulopathies. ´ Headaches, migraines. ´ Systemic lupus erythematosus (...) Oestrogen-progestogen contraceptive methods (COC, patch, CCVR) Minor surgery without immobilisation All methods Superficial thrombophlebitis Progestogen-only methods (PMP, progestogen-only injectable, implant), LNG-IUD, Cu-IUD, barrier, natural methods Oestrogen-progestogen contraceptive methods* (COC, patch, CCVR) History of STP or spontaneous STP in healthy veins Progestogen-only methods (PMP, progestogen-only injectable, implant), LNG-IUD, Cu-IUD, barrier, natural methods Oestrogen-progestogen

2013 HAS Guidelines

146. Magnetic Resonance Imaging

selected MRI pulse sequences in order to visualize the blood vessels (arteries). There are three major families of MRA techniques: time of flight (TOF) or inflow angiography, phase contrast (PC) angiography (related to the phase shift of the flowing proton spins) and dynamic gadolinium-enhanced (DGE) MRA. Quantification of flow is also possible using phase contrast acquisitions. Similarly several methods are available to image the deep and superficial venous sinuses with MRI, including contrast

2011 Canadian Association of Radiologists

147. Investigation and Management of Antiphospholipid Syndrome

). Venous thrombosis in APS is most commonly lower limb deep vein thrombosis (DVT) and/or pulmonary embolism (PE) but any part of the venous system may be involved, including superficial, portal, renal, mesenteric and intracranial veins. The most frequent site of arterial thrombosis in APS is in the cerebral vasculature resulting in transient cerebral ischaemia/stroke. Myocardial infarction is less common, although subclinical myocardial ischaemia may be under‐recognized (Sacre et al , ). Despite

2012 British Committee for Standards in Haematology

148. Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery

Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery (SUPERB) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00933270 Recruitment Status : Completed First Posted : July 7, 2009 Results First Posted : March 25, 2015 Last Update Posted : May 30, 2017 Sponsor: Abbott Medical Devices

2009 Clinical Trials

149. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum

thrombosis (DVT), deep venous obstruction, superficial thrombophlebitis, or arteriovenous fistula. Varicose veins may also be congenital and present as a venous malformation. Varicosities are manifestations of CVD. x 51 Eklof, B., Perrin, M., Delis, K.T., Rutherford, R.B., Gloviczki, P. et al. Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document. J Vasc Surg . 2009 ; 49 : 498–501 | | | | | , x 52 Caggiati, A., Bergan, J.J., Gloviczki, P (...) Reuse portions or extracts from the article in other works Redistribute or republish the final article Sell or re-use for commercial purposes | ---- Fig 1 Medial superficial and perforating veins of the lower limb. ---- | Fig 2 Posterior superficial and perforating veins of the leg. Hide Pane Expand all Collapse all Article Outline The Society for Vascular Surgery (SVS) and the American Venous Forum (AVF) have developed clinical practice guidelines for the care of patients with varicose veins

Full Text available with Trip Pro

2011 Society for Vascular Surgery

151. Management of Patients with Infections Caused by Methicillin-Resistant Staphylococcus Aureus

abscess [ ]. Bacteremia accompanies the majority (75%) of cases of invasive MRSA disease [ ]. A multitude of disease manifestations have been described, including, but not limited to, infective endocarditis; myocardial, peri-nephric, hepatic, and splenic abscesses; septic thrombophlebitis with and without pulmonary emboli [ ]; necrotizing pneumonia [ ]; osteomyelitis complicated by subperiosteal abscesses; venous thrombosis and sustained bacteremia [ , , ]; severe ocular infections, including (...) of invasive susceptible CA-MRSA infections in children, including osteomyelitis, septic arthritis, pneumonia, and lymphadenitis [ , ]. Because it is bacteriostatic, it is not recommended for endovascular infections, such as infective endocarditis or septic thrombophlebitis. Clindamycin has excellent tissue penetration, particularly in bone and abscesses, although penetration into the CSF is limited [ ]. In vitro rates of susceptibility to clindamycin are higher among CA-MRSA than they are among HA-MRSA

Full Text available with Trip Pro

2011 Infectious Diseases Society of America

152. Behçet's pulmonary artery aneurysms treated with infliximab and monitored with the 6-min walk test (PubMed)

Behçet's pulmonary artery aneurysms treated with infliximab and monitored with the 6-min walk test Pulmonary involvement in Behçet's disease (BD) is uncommon; however, it is potentially fatal due to the risk of massive haemoptysis. We describe the case of a 36-year-old male presenting with a 2-month history of worsening dyspnoea, weight loss, haemoptysis, oral ulceration, erythema nodosum and superficial thrombophlebitis. He was diagnosed with pulmonary vasculitis secondary to BD; however, his

Full Text available with Trip Pro

2016 Oxford Medical Case Reports

153. The DESappear Study: Drug Eluting Scaffold

changes; Subject has a groin infection, or an acute systemic infection that has not been treated successfully or is currently under treatment; Subject has acute thrombophlebitis (superficial or deep) in either extremity; Subject has other medical conditions (e.g., cancer, congestive heart failure or substance abuse) that may cause the subject to be non-compliant with protocol requirements or confound data interpretation; Subject is currently participating or wanting to participate in a clinical trial (...) General Hospital Genae Information provided by (Responsible Party): Elixir Medical Corporation Study Details Study Description Go to Brief Summary: The aim of this study is to prospectively collect information to evaluate the safety and performance of the Akesys Prava Sirolimus Eluting Bioresorbable Peripheral scaffold system for the treatment of symptomatic primary atherosclerotic stenoses and occlusions of the superficial femoral artery (SFA). Condition or disease Intervention/treatment Phase

2016 Clinical Trials

154. Study to Assess the Efficacy and Safety of Endolex Forte VErsus Diosmin and Hesperidin in Reducing VeNous Insufficiency

research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: 18 Years to 75 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: Patients, male or females aged 18 to 75 years old BMI≤40 Presence of chronic venous insufficiency which is rated between functional classes CEAP 1-4 Patients diagnosed with superficial vein thrombophlebitis and have skin reaction

2016 Clinical Trials

155. Clinical Study of Stent Versus Direct Atherectomy to Treat Arteriosclerosis Occlusive Disease of Lower Extremity

Hospital, Beijing. Recruitment status was: Recruiting First Posted : July 21, 2016 Last Update Posted : July 21, 2016 Sponsor: Xuanwu Hospital, Beijing Collaborators: Beijing Friendship Hospital Beijing Chao Yang Hospital Information provided by (Responsible Party): Xuanwu Hospital, Beijing Study Details Study Description Go to Brief Summary: This is a randomized study comparing stent and plaque excision systems in treatment of Arteriosclerosis occlusive disease of lower extremity (superficial femoral (...) or popliteal artery) Condition or disease Intervention/treatment Phase Atherosclerosis Ischemia Device: plaque excision system Device: Stent Not Applicable Detailed Description: This is a randomized study comparing stent and plaque excision systems in treatment of Arteriosclerosis occlusive disease of lower extremity (superficial femoral or popliteal artery) Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 120 participants Allocation

2016 Clinical Trials

156. Predicting and preventing thromboembolic events in patients receiving cisplatin-based chemotherapy for germ cell tumours. (PubMed)

in patients at risk of deep venous thrombosis (DVT).Between 2001 and 2014, 295 patients received first-line cisplatin-based chemotherapy for GCT. Preventive anticoagulation with low-molecular-weight heparin (LMWH) was progressively implemented in patients with predictive factors. Sixteen patients with evidence of TEE before starting chemotherapy were excluded from the analysis.Among 279 eligible patients, a TEE occurred in 38 (14%) consisting of DVT (n = 26), arterial thrombosis (n = 2), and superficial (...) thrombophlebitis (n = 10). DVT occurred in 26 (12.7%) of 204 patients with risk factors versus two (2.6%) of 75 patients with no risk factors (p = 0.01). After a prevention protocol was progressively implemented from 2005, primary thromboprophylaxis was administered to 104 patients (68%) with risk factors. Among patients at risk (n = 151), the incidence of DVT decreased by roughly half when they received a LMWH: 9/97 (9.2%) and 9/54 (16.6%), respectively (p = 0.23).Patients with GCT who receive cisplatin-based

2016 European Journal of Cancer

157. Deep Vein Thrombosis

) Reduced with below knee graded Encourage 30 minute walk per day ( ) Painful, white leg following ileo-femoral deep vein obstruction Painful, cyanotic, edematous leg following ileo-femoral deep and superficial vein obstruction (capillary obstruction) results if not promptly managed XIII. Precautions Idiopathic DVT associated with undiagnosed malignancy Initiate evaluation for underlying malignancy in the first month of unprovoked DVT Directed history and physical Consider , , , PSA of malignancy (...) , Blodproppsykdommer , Tromboembolisk sykdom Derived from the NIH UMLS ( ) Ontology: Deep Vein Thrombosis (C0149871) Definition (MEDLINEPLUS) Deep vein thrombosis, or DVT, is a that forms in a vein deep in the body. Most deep vein clots occur in the lower leg or thigh. If the vein swells, the condition is called thrombophlebitis. A deep vein thrombosis can break loose and cause a serious problem in the lung, called a . Sitting still for a long time can make you more likely to get a DVT. Some medicines

2018 FP Notebook

158. Behcet's Syndrome

of the symptoms. There is no cure. Treatment focuses on reducing pain and preventing serious problems. Most people can control symptoms with treatment. NIH: National Institute of Arthritis and Musculoskeletal and Skin Diseases Definition (NCI) A rare chronic inflammatory disorder of unknown etiology. It is characterized by the development of ulcers in the mouth and genital region and uveitis. Other signs and symptoms include arthritis, deep vein thrombosis and superficial thrombophlebitis. Definition (CSP (...) ) rare chronic inflammatory disease involving the small blood vessels; of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon; the neuroocular form may cause blindness and death; synovitis, thrombophlebitis, gastrointestinal ulcerations, retinal vasculitis, and optic atrophy may occur as well. Definition (MSH) Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized

2018 FP Notebook

159. Catheter-directed Foam Sclerotherapy With Tumescence

Secondary Outcome Measures : Quality of Life Change [ Time Frame: Six months follow-up after the intervention ] It will be measured by the application of the Aberdeen varicose vein questionnaire Complications [ Time Frame: From the intervention until six months follow-up ] It will be considered: anaphylaxis; superficial thrombophlebitis; deep venous thrombosis; pulmonary embolism; visual disturbances; migraine; transient ischemic attack; tissue necrosis; intra arterial injection; neurological injury

2016 Clinical Trials

160. Long Segment Lesion Peripheral Artery Revascularization Feasibility Study

, 2017 See Sponsor: PQ Bypass, Inc. Information provided by (Responsible Party): PQ Bypass, Inc. Study Details Study Description Go to Brief Summary: The primary objective of the feasibility study is to evaluate the safety and effectiveness of the PQ Bypass Stent Graft System in the treatment of atherosclerotic lesions of the native superficial femoral artery (SFA) or the superficial femoral and proximal popliteal arteries. Condition or disease Intervention/treatment Phase Peripheral Arterial Disease (...) Experimental: PQ Bypass Stent Graft System The PQ Bypass™ Stent Graft System is intended for patients with atherosclerotic lesions of the SFA Device: PQ Bypass Stent Graft System The PQ Bypass™ Stent Graft System is indicated to improve luminal diameter in the treatment of patients with symptomatic de novo or restenotic native lesions or occlusions of the superficial femoral artery (SFA) and/or proximal popliteal artery, with reference vessel diameters of 5.0 to 6.7 mm and lesion lengths up to 180 mm

2016 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>